Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
9.61
-0.19 (-1.94%)
At close: Jul 2, 2026, 4:00 PM EDT
9.78
+0.17 (1.77%)
After-hours: Jul 2, 2026, 7:16 PM EDT
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $466.93 million as of July 2, 2026. Its market cap has increased by 964.75% in one year.
Market Cap
466.93M
Enterprise Value
390.41M
1-Year Change
964.75%
Ranking
Category
Stock Price
$9.61
Market Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has increased from $176.76M to $466.93M, an increase of 164.17%. That is a compound annual growth rate of 64.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 466.93M | 343.44% |
| Dec 31, 2025 | 105.30M | -56.99% |
| Dec 31, 2024 | 244.84M | 38.52% |
| Jul 19, 2024 | 176.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zura Bio | 491.14M |
| Silence Therapeutics | 490.76M |
| Valneva SE | 487.25M |
| Prelude Therapeutics | 486.96M |
| C4 Therapeutics | 475.44M |
| Sagimet Biosciences | 469.93M |
| Evommune | 466.80M |
| Benitec Biopharma | 453.99M |